Aardvark Therapeutics, Inc. (NASDAQ:AARD) Short Interest UpdateMarket Beat·Jul 16 at 05:20 AMAARD-1.10%WFC+0.14%
12 Health Care Stocks Moving In Friday's After-Market Sessionbenzinga_article·Jul 10 at 04:05 PMOKYO+4.73%UPC-10.55%
Aardvark Therapeutics (AARD) Faces Investor Scrutiny Amid 56% Drop On Clinical Pause For Lead Drug Candidate- HBSSPR Newswire·May 28 at 08:00 AMAARD-1.10%
18:40 ETINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aardvark Therapeutics, Inc. - AARDprnewswire·May 21 at 05:42 PMAARD-1.10%
North American Morning Briefing: Stock Futures Slip Amid Mideast, Inflation PessimismMorningStar·May 18 at 05:19 AM.DJI+0.46%.IXIC-0.64%
FDA Clinical Hold, Competitive Pressure Drive Aardvark Therapeutics Downgrade as Price Target Slashed from $18 to $4Tip Ranks·May 17 at 04:06 PMAARD-1.10%
<![CDATA[FDA Places Full Clinical Hold on Aardvark Therapeutics’ ARD-101]]>Pharmexec·May 15 at 08:56 AMAARD-1.10%
12 Health Care Stocks Moving In Friday's Pre-Market Sessionbenzinga_article·May 15 at 07:06 AMHCWB-13.19%PIII+3.33%
